Pio R - Search Results

1

The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cells.

Senent Y, Tavira B, Pio R, Ajona D. Senent Y, et al. Among authors: pio r. Cancer Lett. 2022 Nov 28;549:215900. doi: 10.1016/j.canlet.2022.215900. Epub 2022 Sep 8. Cancer Lett. 2022. PMID: 36087681 Free article. Review.

2

Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.

Ajona D, Castaño Z, Garayoa M, Zudaire E, Pajares MJ, Martinez A, Cuttitta F, Montuenga LM, Pio R. Ajona D, et al. Among authors: pio r. Cancer Res. 2004 Sep 1;64(17):6310-8. doi: 10.1158/0008-5472.CAN-03-2328. Cancer Res. 2004. PMID: 15342420

3

Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth.

Ajona D, Hsu YF, Corrales L, Montuenga LM, Pio R. Ajona D, et al. Among authors: pio r. J Immunol. 2007 May 1;178(9):5991-8. doi: 10.4049/jimmunol.178.9.5991. J Immunol. 2007. PMID: 17442984

4

Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors.

Okroj M, Hsu YF, Ajona D, Pio R, Blom AM. Okroj M, et al. Among authors: pio r. Mol Immunol. 2008 Jan;45(1):169-79. doi: 10.1016/j.molimm.2007.04.025. Epub 2007 Jun 4. Mol Immunol. 2008. PMID: 17548110

5

Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo.

Hsu YF, Ajona D, Corrales L, Lopez-Picazo JM, Gurpide A, Montuenga LM, Pio R. Hsu YF, et al. Among authors: pio r. Mol Cancer. 2010 Jun 7;9:139. doi: 10.1186/1476-4598-9-139. Mol Cancer. 2010. PMID: 20529262 Free PMC article.

6

Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.

Pio R, Garcia J, Corrales L, Ajona D, Fleischhacker M, Pajares MJ, Cardenal F, Seijo L, Zulueta JJ, Nadal E, Witt C, Lozano MD, Schmidt B, Montuenga LM. Pio R, et al. Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2665-72. doi: 10.1158/1055-9965.EPI-10-0467. Epub 2010 Aug 27. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20802023

7

Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.

Corrales L, Ajona D, Rafail S, Lasarte JJ, Riezu-Boj JI, Lambris JD, Rouzaut A, Pajares MJ, Montuenga LM, Pio R. Corrales L, et al. Among authors: pio r. J Immunol. 2012 Nov 1;189(9):4674-83. doi: 10.4049/jimmunol.1201654. Epub 2012 Oct 1. J Immunol. 2012. PMID: 23028051 Free PMC article.

8

Complement inhibition in cancer therapy.

Pio R, Ajona D, Lambris JD. Pio R, et al. Semin Immunol. 2013 Feb;25(1):54-64. doi: 10.1016/j.smim.2013.04.001. Epub 2013 May 24. Semin Immunol. 2013. PMID: 23706991 Free PMC article. Review.

9

Silica-induced chronic inflammation promotes lung carcinogenesis in the context of an immunosuppressive microenvironment.

Freire J, Ajona D, de Biurrun G, Agorreta J, Segura V, Guruceaga E, Bleau AM, Pio R, Blanco D, Montuenga LM. Freire J, et al. Among authors: pio r. Neoplasia. 2013 Aug;15(8):913-24. doi: 10.1593/neo.13310. Neoplasia. 2013. PMID: 23908592 Free PMC article.

10

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

Ajona D, Pajares MJ, Corrales L, Perez-Gracia JL, Agorreta J, Lozano MD, Torre W, Massion PP, de-Torres JP, Jantus-Lewintre E, Camps C, Zulueta JJ, Montuenga LM, Pio R. Ajona D, et al. Among authors: pio r. J Natl Cancer Inst. 2013 Sep 18;105(18):1385-93. doi: 10.1093/jnci/djt205. Epub 2013 Aug 12. J Natl Cancer Inst. 2013. PMID: 23940286 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page